Get a deeper insight into the potential performance of Ventas (VTR) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some o
While VTR's Q1 earnings are likely to have benefited from favorable SHOP operating trends and a well-diversified tenant base, high interest expenses may have hurt it.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?

The State Of REITs: April 2025 Edition

12:22pm, Monday, 21'st Apr 2025
REITs finished the first quarter of 2025 in the red (-3.36%) with a brutal -4.92% average total return in March. Large cap (-2.04%) and mid cap REITs (-2.63%) saw modest losses, but small caps (-4.16%
First-quarter earnings season is in full swing. But investors playing the long game want to know which S&P 500 companies will profit most.
Aging population, rising healthcare expenses, favorable outpatient visit trends and accretive investments in its research portfolio are likely to support VTR.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?
Ventas is a well-run REIT that's experiencing high growth, particularly in its SHOP portfolio. It carries a strong balance sheet and management has resumed meaningful dividend growth. The recent dip i
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its first quarter 2025 earnings release after the close of trading on the New York Stock Exchange on Wednesday, April 30, 2025. A conferen
Rising healthcare expenditures and an aging population support VTR's senior housing operating portfolio despite competition and tenant concentration risks.

Cramer's Stop Trading: Ventas

10:22am, Thursday, 03'rd Apr 2025
Jim Cramer breaks down why he's keeping an eye on shares of Ventas.
Ventas (VTR) reported earnings 30 days ago. What's next for the stock?
VTR is set to gain from rising healthcare spending amid an aging population. Accretive investments in the research portfolio and solid balance sheet bode well.
VTR is likely to gain from an aging population, rising healthcare expenses, favorable outpatient visit trends and accretive investments in its research portfolio.
Demographic shifts, including an aging population and migration trends, are key drivers of REIT performance, influencing sector allocations and investment strategies. Chilton focuses on single-family
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE